Income Taxes

9 Months Ended

Sep. 30, 2025

Income Tax Disclosure [Abstract]

Income Taxes [Text Block]

NOTE 6 - Income Taxes

A summary of the reconciliation of the income tax benefit based on the statutory federal income tax rate of 21% to the income tax expense (benefit) reported in these financial statements for the three and nine months ended September 30, 2025 and 2024 is as follows:

	Three months ended September 30,				Nine months ended September 30,
	2025		2024		2025		2024
	$		$		$		$
Income tax benefit computed at federal statutory rates	(2,168,863	)	(2,097,055	)	(4,341,404	)	(5,829,895	)
Change in valuation allowance	2,225,038		2,079,390		4,433,232		5,725,403
Non-deductible stock-based compensation	(19,490	)	-		(78,253	)	47,019
Other	(18,133	)	1,680		17,462		13,449
Total income tax expense (benefit)	18,552		(15,985	)	31,037		(44,024	)

The effective tax rates for the three and nine months ended September 30, 2025 were 0.15% and 0.18%, respectively. The effective tax rates for the three and nine months ended September 30, 2025 and 2024 were less than the statutory rate as the Company does not expect to realize a benefit from a portion of the losses incurred.